Tiziana Life Sciences Plc: Tiziana Reports Positive Data from the Clinical Study of Nasal Administration with Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, in COVID-19 Patients in Brazil
85
All treatments were well-tolerated. There were no grade 3 or 4 severe adverse events ( SAEs ) in any of the cohorts.
The CT scans of the lungs showed the improvement was approximately double that shown in patients treated with Foralumab as compared to those in the control group.
Medical records of patients also showed a more rapid recovery in senses of smell and taste in Foralumab treated patients, as compared to those in the control group.
Uspaskichas nesustoja: pareklamavęs vandenį, puola vakcinų gamintoją delfi.lt - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from delfi.lt Daily Mail and Mail on Sunday newspapers.
Credit: NIH/NINDS
Analysis from a workshop convened by the National Institute of Neurological Disorders and Stroke (NINDS) in 2017 reveals gaps in and opportunities for research to improve understanding of the effects of traumatic brain injury (TBI) in women. A new paper in the
Journal of Head Trauma Rehabilitation summarizes and updates the findings presented during the Understanding Traumatic Brain Injury in Women workshop and provides strategies for advancing research efforts in this area. NINDS is part of the National Institutes of Health. We are making advances in understanding the effects of head injury on the brain, but many of these studies have been done in males, said Patrick Bellgowan, Ph.D., program director at NINDS. There is evidence that traumatic brain injury affects women differently, but we need focused research efforts to get a full understanding of those differences to help improve prevention and treatment strategies.